Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
F 32.08 -2.37% -0.78
QURE closed up 7.81 percent on Thursday, May 6, 2021, on 1.44 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical QURE trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -2.37%
50 DMA Resistance Bearish -2.37%
Gapped Up Strength -2.37%
Oversold Stochastic Weakness -2.37%
Doji - Bullish? Reversal 5.25%
Multiple of Ten Bullish Other 5.25%
Below Lower BB Weakness 5.25%
Lower Bollinger Band Touch Weakness 5.25%
Oversold Stochastic Weakness 5.25%
180 Bearish Setup Bearish Swing Setup 3.65%
Older End-of-Day Signals for QURE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day 12 minutes ago
Possible NR7 12 minutes ago
Down 2 % 29 minutes ago
60 Minute Opening Range Breakdown about 1 hour ago
Down 1% about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

uniQure N.V. Description

uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Diseases Clinical Development Genetics Gene Therapy Parkinson's Disease Metabolic Disease Applied Genetics Hemophilia Gene Delivery Lipoprotein Adeno Associated Virus Treatment Of Hemophilia Lipase Acute Intermittent Porphyria Alipogene Tiparvovec Glybera Hemophilia B Lipoprotein Lipase Deficiency

Is QURE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 71.45
52 Week Low 28.58
Average Volume 473,917
200-Day Moving Average 38.59
50-Day Moving Average 33.52
20-Day Moving Average 33.28
10-Day Moving Average 32.85
Average True Range 1.99
ADX 10.01
+DI 23.88
-DI 20.95
Chandelier Exit (Long, 3 ATRs ) 30.13
Chandelier Exit (Short, 3 ATRs ) 35.96
Upper Bollinger Band 35.81
Lower Bollinger Band 30.75
Percent B (%b) 0.42
BandWidth 15.22
MACD Line -0.49
MACD Signal Line -0.31
MACD Histogram -0.1813
Fundamentals Value
Market Cap 1.46 Billion
Num Shares 44.5 Million
EPS -2.80
Price-to-Earnings (P/E) Ratio -11.76
Price-to-Sales 368.82
Price-to-Book 9.86
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.76
Resistance 3 (R3) 35.74 34.76 35.27
Resistance 2 (R2) 34.76 34.02 34.77 35.11
Resistance 1 (R1) 33.81 33.57 33.32 33.83 34.95
Pivot Point 32.83 32.83 32.59 32.84 32.83
Support 1 (S1) 31.88 32.09 31.39 31.90 30.77
Support 2 (S2) 30.90 31.64 30.91 30.61
Support 3 (S3) 29.95 30.90 30.45
Support 4 (S4) 29.97